FDA NDC Directory · JSON-LD · Markdown

RHAPSIDO

NDC 0078-1483 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameremibrutinib
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA218436
Dosage form / routeTABLET · ORAL
Active ingredientsREMIBRUTINIB (25 mg/1)
Marketing started20250930
Package count3

External sources

Source: openFDA. Public-domain (CC0).